FDA.reportPublic FDA data

Buprenorphine IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of buprenorphine in a clinical specimen.
GUDID devices
7
Last updated
2020-03-17 21:44:15

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00840937104934Immunalysis CorporationIMMUNALYSIS CORPORATIONPOS-236-22016-08-31
00840937104941Immunalysis CorporationIMMUNALYSIS CORPORATIONPOS-236-52016-08-31
00840937105573Immunalysis CorporationIMMUNALYSIS CORPORATIONCB-4362016-08-31
00840937105979Immunalysis CorporationIMMUNALYSIS CORPORATIONCP-2362016-08-31
00840937107072Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-236-152016-08-31
00840937107089Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-236-602016-08-31
00840937107096Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-236-7502016-08-31